895 related articles for article (PubMed ID: 28656474)
1. Dissecting Kawasaki disease: a state-of-the-art review.
Dietz SM; van Stijn D; Burgner D; Levin M; Kuipers IM; Hutten BA; Kuijpers TW
Eur J Pediatr; 2017 Aug; 176(8):995-1009. PubMed ID: 28656474
[TBL] [Abstract][Full Text] [Related]
2. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.
Friedman KG; Gauvreau K; Hamaoka-Okamoto A; Tang A; Berry E; Tremoulet AH; Mahavadi VS; Baker A; deFerranti SD; Fulton DR; Burns JC; Newburger JW
J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27633390
[TBL] [Abstract][Full Text] [Related]
3. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
[TBL] [Abstract][Full Text] [Related]
4. Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol.
Eleftheriou D; Moraes YC; Purvis C; Pursell M; Morillas MM; Kahn R; Mossberg M; Kucera F; Tulloh R; Standing JF; Swallow V; McCormack R; Herberg J; Levin M; Wan M; Klein N; Connon R; Walker AS; Brogan P
Trials; 2023 Jan; 24(1):60. PubMed ID: 36703139
[TBL] [Abstract][Full Text] [Related]
5. [Kawasaki disease in children--9 years experience].
Kowalczyk M; Kawalec W; Daszkowska-York J; Turska-Kmieć A; Brzezińska-Rajszys G; Sobielarska D; Ziółkowska L; Kościesza A; Jagiełłowicz D; Mirecka-Rola A
Med Wieku Rozwoj; 2005; 9(2):179-93. PubMed ID: 16085959
[TBL] [Abstract][Full Text] [Related]
6. Giant aneurysms: A gender-specific complication of Kawasaki disease?
Dietz SM; Kuipers IM; Tacke CEA; Koole JCD; Hutten BA; Kuijpers TW
J Cardiol; 2017 Oct; 70(4):359-365. PubMed ID: 28325522
[TBL] [Abstract][Full Text] [Related]
7. [Kawasaki disease in adult patients].
Sève P; Lega JC
Rev Med Interne; 2011 Jan; 32(1):17-25. PubMed ID: 20537446
[TBL] [Abstract][Full Text] [Related]
8. The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease.
Samadli S; Liu FF; Mammadov G; Wang JJ; Liu HH; Wu YF; Luo HH; Wu Y; Chen WX; Zhang DD; Wei W; Hu P
Pediatr Rheumatol Online J; 2019 Jul; 17(1):53. PubMed ID: 31366406
[TBL] [Abstract][Full Text] [Related]
9. Low risk of treatment resistance in Down syndrome with Kawasaki disease.
Takatsuki S; Ogata S; Ishii M; Yokozawa M; Ono M; Fujiwara M; Ida H; Motomura H; Moriuchi H; Taketazu M; Kawamura Y; Kawano T; Izumi T; Shiono J; Tsuchiya S; Tsuchiya K; Goushi T; Ichida F; Saji T
Pediatr Int; 2017 Dec; 59(12):1236-1239. PubMed ID: 28960680
[TBL] [Abstract][Full Text] [Related]
10. The Harada score in the US population of children with Kawasaki disease.
Tewelde H; Yoon J; Van Ittersum W; Worley S; Preminger T; Goldfarb J
Hosp Pediatr; 2014 Jul; 4(4):233-8. PubMed ID: 24986993
[TBL] [Abstract][Full Text] [Related]
11. Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events.
Miura M; Kobayashi T; Kaneko T; Ayusawa M; Fukazawa R; Fukushima N; Fuse S; Hamaoka K; Hirono K; Kato T; Mitani Y; Sato S; Shimoyama S; Shiono J; Suda K; Suzuki H; Maeda J; Waki K; ; Kato H; Saji T; Yamagishi H; Ozeki A; Tomotsune M; Yoshida M; Akazawa Y; Aso K; Doi S; Fukasawa Y; Furuno K; Hayabuchi Y; Hayashi M; Honda T; Horita N; Ikeda K; Ishii M; Iwashima S; Kamada M; Kaneko M; Katyama H; Kawamura Y; Kitagawa A; Komori A; Kuraishi K; Masuda H; Matsuda S; Matsuzaki S; Mii S; Miyamoto T; Moritou Y; Motoki N; Nagumo K; Nakamura T; Nishihara E; Nomura Y; Ogata S; Ohashi H; Okumura K; Omori D; Sano T; Suganuma E; Takahashi T; Takatsuki S; Takeda A; Terai M; Toyono M; Watanabe K; Watanabe M; Yamamoto M; Yamamura K
JAMA Pediatr; 2018 May; 172(5):e180030. PubMed ID: 29507955
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Kawasaki Disease: A Single-Center Experience.
Uysal F; Bostan OM; Celebi S; Uysal B; Hamitoglu S; Cil E
Clin Pediatr (Phila); 2015 Jun; 54(6):579-84. PubMed ID: 25475592
[TBL] [Abstract][Full Text] [Related]
13. Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial).
Tremoulet AH; Jain S; Kim S; Newburger J; Arditi M; Franco A; Best B; Burns JC
Contemp Clin Trials; 2016 May; 48():70-5. PubMed ID: 27080929
[TBL] [Abstract][Full Text] [Related]
14. [Immunoglobulin therapy].
Ogata S; Ishii M
Nihon Rinsho; 2014 Sep; 72(9):1617-22. PubMed ID: 25518412
[TBL] [Abstract][Full Text] [Related]
15. [Kawasaki disease: what you need to know].
Bajolle F; Laux D
Arch Pediatr; 2012 Nov; 19(11):1264-8. PubMed ID: 22921712
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
Newburger JW; Takahashi M; Gerber MA; Gewitz MH; Tani LY; Burns JC; Shulman ST; Bolger AF; Ferrieri P; Baltimore RS; Wilson WR; Baddour LM; Levison ME; Pallasch TJ; Falace DA; Taubert KA;
Pediatrics; 2004 Dec; 114(6):1708-33. PubMed ID: 15574639
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
Newburger JW; Takahashi M; Gerber MA; Gewitz MH; Tani LY; Burns JC; Shulman ST; Bolger AF; Ferrieri P; Baltimore RS; Wilson WR; Baddour LM; Levison ME; Pallasch TJ; Falace DA; Taubert KA; ; ; ;
Circulation; 2004 Oct; 110(17):2747-71. PubMed ID: 15505111
[TBL] [Abstract][Full Text] [Related]
18. A Comprehensive Update on Kawasaki Disease Vasculitis and Myocarditis.
Soni PR; Noval Rivas M; Arditi M
Curr Rheumatol Rep; 2020 Feb; 22(2):6. PubMed ID: 32020498
[TBL] [Abstract][Full Text] [Related]
19. Kawasaki disease: a comprehensive review of treatment options.
Patel RM; Shulman ST
J Clin Pharm Ther; 2015 Dec; 40(6):620-5. PubMed ID: 26547265
[TBL] [Abstract][Full Text] [Related]
20. Kawasaki Disease: Beyond IVIG and Aspirin.
Moussa T; Wagner-Weiner L
Pediatr Ann; 2019 Oct; 48(10):e400-e405. PubMed ID: 31609999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]